Search Results - "Oshagbemi, Olorunfemi A"

  • Showing 1 - 11 results of 11
Refine Results
  1. 1

    Estimated distribution of malaria cases among children in sub-Saharan Africa by specified age categories using data from the Global Burden of Diseases 2019 by Oshagbemi, Olorunfemi A, Lopez-Romero, Pedro, Winnips, Cornelis, Csermak, Katalin R, Su, Guoqin, Aubrun, Elodie

    Published in Malaria journal (05-12-2023)
    “…Children in sub-Saharan Africa (SSA) remain the most vulnerable to malaria and malaria mortality. This study estimated the disease burden and distribution of…”
    Get full text
    Journal Article
  2. 2

    Blood eosinophilia, use of inhaled corticosteroids, and risk of COPD exacerbations and mortality by Oshagbemi, Olorunfemi A., Franssen, Frits M.E., Braeken, Dionne C.W., Henskens, Yvonne, Wouters, Emiel F.M., Maitland‐van der Zee, Anke‐Hilse, Burden, Andrea M., Vries, Frank

    Published in Pharmacoepidemiology and drug safety (01-11-2018)
    “…Purpose It remains unclear whether eosinophilia is useful for in guiding inhaled corticosteroid (ICS) therapy in chronic obstructive pulmonary disease (COPD)…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8

    Use of high-dose intermittent systemic glucocorticoids and the risk of fracture in patients with chronic obstructive pulmonary disease by Oshagbemi, Olorunfemi A., Burden, Andrea M., Shudofsky, Kimberly N., Driessen, Johanna H.M., Vestergaard, Peter, Krings, Andreas, Franssen, Frits M.E., van den Bergh, Joop, de Vries, Frank

    Published in Bone (New York, N.Y.) (01-05-2018)
    “…Chronic obstructive pulmonary disease (COPD) is characterised by persistent airflow obstruction and respiratory symptoms. While short course systemic GCs are…”
    Get full text
    Journal Article
  9. 9

    Trends in moderate and severe exacerbations among COPD patients in the UK from 2005 to 2013 by Oshagbemi, Olorunfemi A., Keene, Spencer J., Driessen, Johanna H.M., Jordan, Rachel, Wouters, Emiel F.M., de Boer, Anthonius, de Vries, Frank, Franssen, Frits M.E.

    Published in Respiratory medicine (01-11-2018)
    “…Exacerbations of chronic obstructive pulmonary disease are characterised by increased symptoms such as dyspnoea, cough and sputum production and/or purulence,…”
    Get full text
    Journal Article
  10. 10

    C-reactive protein as a biomarker of response to inhaled corticosteroids among patients with COPD by Oshagbemi, Olorunfemi A., Franssen, Frits M.E., Wouters, Emiel F.M., Maitland-van der Zee, Anke H., Driessen, Johanna H.M., de Boer, Anthonius, de Vries, Frank

    Published in Pulmonary pharmacology & therapeutics (01-02-2020)
    “…C-reactive protein (CRP) is an important biomarker in systemic inflammation in COPD; reports have suggested inhaled corticosteroids (ICS) attenuate CRP levels…”
    Get full text
    Journal Article
  11. 11